van Zuylen L - Search Results

1

Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study.

Slotman E, Fransen HP, van Laarhoven HW, van den Beuken-van Everdingen MH, Tjan-Heijnen VC, Huijben AM, Jager A, van Zuylen L, Kuip EJ, van der Linden YM, Raijmakers NJ, Siesling S. Slotman E, et al. Among authors: van zuylen l. Palliat Med. 2024 Jan;38(1):140-149. doi: 10.1177/02692163231217373. Epub 2023 Dec 23. Palliat Med. 2024. PMID: 38142283 Free PMC article.

2

Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.

van Zuylen L, Verweij J, Nooter K, Brouwer E, Stoter G, Sparreboom A. van Zuylen L, et al. Clin Cancer Res. 2000 Jul;6(7):2598-603. Clin Cancer Res. 2000. PMID: 10914699

3

Swallowing problems at the end of the palliative phase: incidence and severity in 164 unsedated patients.

Bogaardt H, Veerbeek L, Kelly K, van der Heide A, van Zuylen L, Speyer R. Bogaardt H, et al. Among authors: van der heide a, van zuylen l. Dysphagia. 2015 Apr;30(2):145-51. doi: 10.1007/s00455-014-9590-1. Epub 2014 Dec 23. Dysphagia. 2015. PMID: 25533181

4

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles.

van Zuylen L, Karlsson MO, Verweij J, Brouwer E, de Bruijn P, Nooter K, Stoter G, Sparreboom A. van Zuylen L, et al. Cancer Chemother Pharmacol. 2001 Apr;47(4):309-18. doi: 10.1007/s002800000215. Cancer Chemother Pharmacol. 2001. PMID: 11345647 Clinical Trial.

5

Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer.

van Zuylen L, Schellens JH, Goey SH, Pronk LC, de Boer-Dennert MM, Loos WJ, Ma J, Stoter G, Verweij J. van Zuylen L, et al. Anticancer Drugs. 1999 Apr;10(4):361-8. doi: 10.1097/00001813-199904000-00003. Anticancer Drugs. 1999. PMID: 10378670 Clinical Trial.

6

Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography.

Loos WJ, de Bruijn P, van Zuylen L, Verweij J, Nooter K, Stoter G, Sparreboom A. Loos WJ, et al. Among authors: van zuylen l. J Chromatogr B Biomed Sci Appl. 1999 Dec 10;735(2):293-7. doi: 10.1016/s0378-4347(99)00414-4. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10670744

7

Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

Sparreboom A, van Zuylen L, Brouwer E, Loos WJ, de Bruijn P, Gelderblom H, Pillay M, Nooter K, Stoter G, Verweij J. Sparreboom A, et al. Among authors: van zuylen l. Cancer Res. 1999 Apr 1;59(7):1454-7. Cancer Res. 1999. PMID: 10197613

8

Role of formulation vehicles in taxane pharmacology.

van Zuylen L, Verweij J, Sparreboom A. van Zuylen L, et al. Invest New Drugs. 2001 May;19(2):125-41. doi: 10.1023/a:1010618632738. Invest New Drugs. 2001. PMID: 11392447 Review.

9

Physicians' and nurses' experiences with continuous palliative sedation in the Netherlands.

Swart SJ, Brinkkemper T, Rietjens JA, Blanker MH, van Zuylen L, Ribbe M, Zuurmond WW, van der Heide A, Perez RS. Swart SJ, et al. Among authors: van der heide a, van zuylen l. Arch Intern Med. 2010 Jul 26;170(14):1271-4. doi: 10.1001/archinternmed.2010.226. Arch Intern Med. 2010. PMID: 20660851 No abstract available.

10

Can the Dying Phase Be Masked by the Use of Dexamethasone? A Case Report.

van Esch HJ, Lokker ME, Geijteman EC, van der Heide A, van Zuylen L. van Esch HJ, et al. Among authors: van der heide a, van zuylen l. J Pain Palliat Care Pharmacother. 2016;30(1):41-3. doi: 10.3109/15360288.2015.1134752. Epub 2016 Feb 9. J Pain Palliat Care Pharmacother. 2016. PMID: 26861486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page